Beskrivning
| Land | Finland |
|---|---|
| Lista | First North Finland |
| Sektor | Finans |
| Industri | Investeringar |
Canatu Plc Company Release 7 November 2024 at 9:00 am EET
Conversion of Canatu Plc’s series B shares to series A shares
The Board of Directors of Canatu Plc (the “Company”) has in its meeting on 24 October 2024 approved requests of certain shareholders of the Company to convert a total of 1,450,000 series B shares held by such shareholders into series A shares in accordance with the articles of association of the Company at a 1:1 conversion rate.
Pursuant to the articles of association of the Company, a series B share shall be considered to have been converted into a series A shares once the entry into the Trade Register has been made. The conversion of the shares has been registered in the Trade Register today on 7 November 2024 and, therefore, the series B shares have been converted to series A shares today.
As a result of the conversion, the number of the Company’s series A shares is in total 11,544,995, the number of series B shares is in total 1,050,000 and the number of series C shares is in total 21,791,821. The conversion does not affect the total number of the Company’s shares or votes. The total number of shares and votes after the conversion is 34,386,816.
The converted series A shares will be admitted to public trading on the Nasdaq First North Growth Market Finland marketplace together with the pre-existing series A shares as of 8 November 2024.
Additional information:
Chair of the Board of Directors Timo Ahopelto, tel. +358 400 569 628
CEO Juha Kokkonen, tel. +358 405 430 367
Certified Adviser
Carnegie Investment Bank AB (publ), tel. +46 (0)73 856 42 65
About Canatu
Canatu (CANATU, Nasdaq First North, Finland) is a fast-growing deep technology company creating advanced carbon nanotubes (Canatu CNTs), related products, and manufacturing equipment for the semiconductor, automotive, and medical diagnostics industries. Canatu partners with forerunner companies, together transforming products for better tomorrows with nano carbon.
Canatu's versatile platform technology has broad potential applications. Its current core includes CNT membranes for extreme ultraviolet (EUV) processes in the semiconductor industry, enabling the manufacturing of the most advanced chips, as well as film heaters for advanced driver-assistance systems (ADAS) in the automotive industry. Additionally, electrochemical sensors for medical diagnostics are in the development phase. Canatu’s patented CNT reactors and Dry DepositionTM method yield clean and pristine CNTs. The company operates through two business models: selling CNT products directly, as well as selling CNT reactors and licensing the related technology so that customers can produce CNT products under a limited license.
Headquartered in Finland, Canatu also operates in the US, Japan, and Taiwan. Founded in 2004 as a spin-off from Aalto University’s Nanomaterials Group, Canatu currently has around 130 employees representing over 30 nationalities, with 20 percent holding or pursuing doctorates. Discover more at www.canatu.com and follow us on LinkedIn.